NICOLE CUMMINS: Open Payments
NPI 1477005783 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 33 payments from 14 companies in 2025. Trend: 2023 $942 · 2024 $1,063 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $98 |
| Janssen Pharmaceuticals, Inc | 3 | $77 |
| Collegium Pharmaceutical, Inc. | 4 | $75 |
| Neurocrine BioSciences, Inc. | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| Braeburn Inc. | 2 | $46 |
| Lundbeck LLC | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
Products named: VRAYLAR, SPRAVATO, Jornay PM, INGREZZA, FANAPT, ABILIFY MAINTENA, AUSTEDO XR, BRIXADI.
Industry payments across UT — which companies pay providers there.
